Dexamethasone Increased Plasminogen Activator Inhibitor-1 Expression on Human Umbilical Vein Endothelial Cells: An Additive Effect to Tumor Necrosis Factor-α
Authors:
- Akihiro IshizuAIAkihiro Ishizu
- Noriyuki OtsukaNONoriyuki Otsuka
- Takashi YoshikiTYTakashi Yoshiki
- 1 December 2004
- journal article
- research article
- Published by S. Karger AG in Pathobiology
- Vol. 71 (6) , 295-301
Abstract
Objective: In patients with autoimmune diseases, blood vessels may be critically involved at the site of inflammation. For these patients, glucocorticoids (GC) are often used as therapeutics. The aim of this study is to determine the effects of GC on vascular endothelial cells which are under inflammatory conditions. Methods: We examined the molecular expressions in human umbilical vein endothelial cells (HUVEC) induced by dexamethasone (Dex) and tumor necrosis factor (TNF)-α. Live cell number of HUVEC under exposure to Dex and TNF-α was also assayed. Results: The cDNA array analysis showed that a number of genes were upregulated, but only a few were downregulated by Dex and TNF-α, respectively. Among them, thrombomodulin (TM) gene showed the least fold change when HUVEC were stimulated by TNF-α. Since TM inhibits blood coagulation, we took notice of molecules associated with coagulation and fibrinolysis. The quantitative real-time RT-PCR revealed that the expression of plasminogen activator inhibitor-1 (PAI-1) gene increased when HUVEC were exposed to Dex and TNF-α, respectively, and the corresponding augmentation of its protein expression was confirmed by immunohistochemistry. The expression of PAI-1 gene additively increased when Dex and TNF-α were added to stimulate HUVEC. Under our experimental conditions, TNF-α induced proliferation of HUVEC. On the other hand, Dex did not change the number of live cells regardless of stimulation by TNF-α. Conclusion: TNF-α can induce proliferation of vascular endothelial cells with downregulation of the anticoagulation molecule, TM, and upregulation of the anti-fibrinolysis molecule, PAI-1. Dex further increased the expression of PAI-1 gene in the cells stimulated by TNF-α, and did not reduce the effect on cell proliferation induced by TNF-α. These findings suggest that the balance of blood coagulation versus fibrinolysis may incline to coagulation when Dex and TNF-α cooperate on vascular endothelial cells.Keywords
This publication has 19 references indexed in Scilit:
- Tumor Necrosis Factor-α-Induced Apoptosis of Human Coronary Artery Endothelial Cells: Modulation by the Peroxisome Proliferator-Activated Receptor-γ Ligand PioglitazoneJournal of Cardiovascular Pharmacology and Therapeutics, 2004
- ThrombomodulinJournal of Thrombosis and Haemostasis, 2003
- Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNFα-induced PAI-1 expressionBlood, 2003
- Osteonecrosis in Patients with SLEClinical Reviews in Allergy & Immunology, 2003
- Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoidsBritish Journal of Pharmacology, 2002
- Occlusive Vascular Diseases in Oral Contraceptive UsersDrugs, 2000
- CORTICOSTEROIDS AND INTERFERONS INHIBIT CYTOKINE-INDUCED PRODUCTION OF IL-8 BY HUMAN ENDOTHELIAL CELLSCytokine, 2000
- Molecular mechanisms of anti‐inflammatory action of glucocorticoidsBioEssays, 1996
- Induction of Endothelial Cell Apoptosis by TNFα: Modulation by Inhibitors of Protein SynthesisExperimental Cell Research, 1994
- Importance of E‐selectin (ELAM‐1) and sialyl lewisa in the adhesion of pancreatic carcinoma cells to acttvated endotheliumInternational Journal of Cancer, 1993